107 related articles for article (PubMed ID: 18221066)
1. Transdermal delivery of 5-fluorouracil for induced ehrlich ascites carcinoma tumor in BALB/c mice and pharmacokinetic study.
Chandrashekar NS; Hiremath SR
Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):235-9. PubMed ID: 18221066
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of 5-fluorouracil from transdermal patches on EAC and DLA cell-induced tumors in mice.
Chandrashekar NS; Prasanth VV
Asian Pac J Cancer Prev; 2008; 9(3):437-40. PubMed ID: 18990017
[TBL] [Abstract][Full Text] [Related]
3. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
Chandrashekar NS; Shobha Rani RH
J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
[TBL] [Abstract][Full Text] [Related]
4. [Antineoplastic activity of 5-fluorouracil upon transdermal adminstration using "Coletex" napkins].
Vartanian LP; Oltarzhevskaia ND; Vershinina SF; Gornaeva GF; Pustovalov IuI; Korovina MA
Vopr Onkol; 2001; 47(4):472-4. PubMed ID: 11710293
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
Li S; Wang A; Jiang W; Guan Z
BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945
[TBL] [Abstract][Full Text] [Related]
6. In vivo immunomodulatory, cumulative skin irritation, sensitization and effect of d-limonene on permeation of 6-mercaptopurine through transdermal drug delivery.
Chandrashekar NS; Hiremath SR
Biol Pharm Bull; 2008 Apr; 31(4):656-61. PubMed ID: 18379058
[TBL] [Abstract][Full Text] [Related]
7. [Microemulsion-based gel of fluorouracil for transdermal delivery].
Xiao YY; Liu F; Chen ZP; Ping QN
Yao Xue Xue Bao; 2010 Nov; 45(11):1440-6. PubMed ID: 21361046
[TBL] [Abstract][Full Text] [Related]
8. [Water in oil microemulsions containing NaCl for transdermal delivery of fluorouracil].
Xiao YY; Liu F; Chen ZP; Ping QN
Yao Xue Xue Bao; 2011 Jun; 46(6):720-6. PubMed ID: 21882535
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of magnetic nanoparticles coated by 5-fluorouracil imprinted polymer for controlled drug delivery in mouse breast cancer model.
Hashemi-Moghaddam H; Kazemi-Bagsangani S; Jamili M; Zavareh S
Int J Pharm; 2016 Jan; 497(1-2):228-38. PubMed ID: 26621688
[TBL] [Abstract][Full Text] [Related]
11. Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil.
Aqil M; Ali A; Sultana Y; Najmi AK
Pharmazie; 2004 Aug; 59(8):631-5. PubMed ID: 15378854
[TBL] [Abstract][Full Text] [Related]
12. The influence of the structure and the composition of water/AOT-Tween 85/IPM microemulsion system on transdermal delivery of 5-fluorouracil.
Yanyu X; Fang L; Qineng P; Hao C
Drug Dev Ind Pharm; 2012 Dec; 38(12):1521-9. PubMed ID: 22324326
[TBL] [Abstract][Full Text] [Related]
13. Locally-applied 5-fluorouracil-loaded slow-release patch prevents pancreatic cancer growth in an orthotopic mouse model.
Shim IK; Yi HJ; Yi HG; Lee CM; Lee YN; Choi YJ; Jeong SY; Jun E; Hoffman RM; Cho DW; Kim SC
Oncotarget; 2017 Jun; 8(25):40140-40151. PubMed ID: 28498800
[TBL] [Abstract][Full Text] [Related]
14. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
Puri R; Jain S
Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
[TBL] [Abstract][Full Text] [Related]
15. [Water in oil microemulsions for transdermal delivery of fluorouracil].
Liu F; Xiao YY; Ping QN; Yang C
Yao Xue Xue Bao; 2009 May; 44(5):540-7. PubMed ID: 19618733
[TBL] [Abstract][Full Text] [Related]
16. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
Safwat MA; Soliman GM; Sayed D; Attia MA
Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: a preliminary study.
Shakeel F; Haq N; Al-Dhfyan A; Alanazi FK; Alsarra IA
Drug Deliv; 2015; 22(4):573-80. PubMed ID: 24350612
[TBL] [Abstract][Full Text] [Related]
18. Microprocessor in controlled transdermal drug delivery of anti-cancer drugs.
Chandrashekar NS; Shobha Rani RH
J Mater Sci Mater Med; 2009 Dec; 20 Suppl 1():S189-94. PubMed ID: 18592348
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
Bocci G; Barbara C; Vannozzi F; Di Paolo A; Melosi A; Barsanti G; Allegrini G; Falcone A; Del Tacca M; Danesi R
Clin Pharmacol Ther; 2006 Oct; 80(4):384-95. PubMed ID: 17015056
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antitumor effects of 5-fluorouracil combined with ultrasound on Ehrlich ascites tumor in vivo.
Mohamed MM; Mohamed MA; Fikry NM
Ultrasound Med Biol; 2003 Nov; 29(11):1635-43. PubMed ID: 14654158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
